Endothelial progenitor cells in pulmonary arterial hypertension

Trends in Cardiovascular Medicine

Volumn 20, Issue 1, 2010, Pages 22-29

  Diller, Gerhard Paul ^a   Thum, Thomas ^b   Wilkins, Martin R ^c   Wharton, John ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

CELL FUNCTION; CELL THERAPY; CLINICAL TRIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; STEM CELL; STEM CELL MOBILIZATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION, PULMONARY; PULMONARY ARTERY; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 78549254182     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.03.003     Document Type: Review

References (87)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Asosingh K., Aldred M.A., Vasanji A., et al. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Pathol 2008, 172:615-627.
3. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222-1232.
4. Berger R.M., Geiger R., Hess J., et al. Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease. Am J Respir Crit Care Med 2001, 163:1493-1499.
5. Budhiraja R., Tuder R.M., Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 2004, 109:159-165.
6. Campbell A.I., Kuliszewski M.A., Stewart D.J. Cell-based gene transfer to the pulmonary vasculature: endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1999, 21:567-575.
7. Campbell A.I., Zhao Y., Sandhu R., et al. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 2001, 104:2242-2248.
8. Case J., Mead L.E., Bessler W.K., et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007, 35:1109-1118.
9. Celermajer D.S., Cullen S., Deanfield J.E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993, 87:440-446.
10. Davie N.J., Crossno J.T., Frid M.G., et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am J Physiol Lung Cell Mol Physiol 2004, 286:L668-L678.
11. Diller G.P., Gatzoulis M.A. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007, 115:1039-1050.
12. Diller G.P., van Eijl S., Okonko D.O., et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation 2008, 117:3020-3030.
13. Dorfmuller P., Perros F., Balabanian K., et al. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003, 22:358-363.
14. Fadini G.P., Agostini C., Avogaro A. Endothelial progenitor cells in cerebrovascular disease. Stroke 2005, 36:1112-1113. author reply 1113.
15. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45:1449-1457.
16. Fadini G.P., Schiavon M., Rea F., et al. Depletion of endothelial progenitor cells may link pulmonary fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2007, 176:724-a-725.
17. Giaid A., Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995, 333:214-221.
18. Haworth S.G. Role of the endothelium in pulmonary arterial hypertension. Vascul Pharmacol 2006, 45:317-325.
19. Hayashida K., Fujita J., Miyake Y., et al. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest 2005, 127:1793-1798.
20. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
21. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:1584-1595.
22. Hristov M., Weber C. Endothelial progenitor cells in vascular repair and remodeling. Pharmacological Research 2008, 58:148-151.
23. Hughes R., Tong J., Oates C., et al. Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension. Chest 2005, 128:617S.
24. Humbert M., Monti G., Brenot F., et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995, 151:1628-1631.
25. Hur J., Yoon C.H., Kim H.S., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288-293.
26. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
27. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
28. JunHui Z., XingXiang W., GuoSheng F., et al. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med 2008, 102:1073-1079.
29. Kanki-Horimoto S., Horimoto H., Mieno S., et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006, 114:I-181-I-185.
30. Lee S.D., Shroyer K.R., Markham N.E., et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998, 101:927-934.
31. Liew A., Barry F., O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006, 28:261-270.
32. Majka S., Alvarez D.F. Neovascular capacity of endothelial progenitor cells in the adult pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 2009, 296:L868-L869.
33. Marsboom G., Pokreisz P., Gheysens O., et al. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. Stem Cells 2008, 26:1017-1026.
34. Mason N.A., Springall D.R., Burke M., et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 1998, 185:313-318.
35. Mata-Greenwood E., Meyrick B., Steinhorn R.H., et al. Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2003, 285:L209-L221.
36. Nagaya N., Kangawa K., Kanda M., et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003, 108:889-895.
37. Oechslin E., Kiowski W., Schindler R., et al. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation 2005, 112:1106-1112.
38. Ormiston M.L., Deng Y., Stewart D.J., et al. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am J Respir Cell Mol Biol 2009.
39. Prater D.N., Case J., Ingram D.A., et al. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007, 21:1141-1149.
40. Pullamsetti S., Kiss L., Ghofrani H.A., et al. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. Faseb J 2005, 19:1175-1177.
41. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2008, 118:2372-2379.
42. Raoul W., Wagner-Ballon O., Saber G., et al. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Respir Res 2007, 8:8.
43. Rehman J., Li J., Orschell C.M., et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
44. Rhodes C.J., Davidson A., Gibbs J.S., et al. Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther 2009, 121:69-88.
45. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
46. Rohde E., Malischnik C., Thaler D., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006, 24:357-367.
47. Sahara M., Sata M., Morita T., et al. Diverse contribution of bone marrow derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 2007, 115:509-517.
48. Satoh K., Fukumoto Y., Nakano M., et al. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. Cardiovasc Res 2009, 81:226-234.
49. Satoh K., Kagaya Y., Nakano M., et al. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation 2006, 113:1442-1450.
50. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210-1221.
51. Shantsila E., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007, 49:741-752.
52. Sieveking D.P., Buckle A., Celermajer D.S., et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008, 51:660-668.
53. Simonneau G., Robbins I.M., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54.
54. Smadja D.M., Gaussem P., Mauge L., et al. Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 2009, 119:374-381.
55. Spees J.L., Whitney M.J., Sullivan D.E., et al. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J 2008, 22:1226-1236.
56. Stenmark K.R., Meyrick B., Galie N., et al. Animal models of pulmonary arterial hypertension: the hope for etiologic discovery and pharmacologic cure. Am J Physiol Lung Cell Mol Physiol 2009.
57. Stewart D.J., Zhao Y.D., Courtman D.W. Cell therapy for pulmonary hypertension: what is the true potential of endothelial progenitor cells?. Circulation 2004, 109:e172-e173. author reply e172-3.
58. Sun C.K., Lee F.Y., Sheu J.J., et al. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats. J Pharmacol Exp Ther 2009, 330:718-726.
59. Takahashi M., Nakamura T., Toba T., et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 2004, 10:771-779.
60. Teichert-Kuliszewska K., Kutryk M.J.B., Kuliszewski M.A., et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006, 98:209-217.
61. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 2005, 46:1693-1701.
62. Tilki D., Hohn H.P., Ergun B., et al. Emerging biology of vascular wall progenitor cells in health and disease. Trends Mol Med 2009.
63. Timmermans F., Plum J., Yöder M.C., et al. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13:87-102.
64. Timmermans F., Van Hauwermeiren F., De Smedt M., et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007, 27:1572-1579.
65. Toshner M., Voswinckel R., Southwood M., et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009, 180:780-787.
66. Ulrich S., Nicolls M.R., Taraseviciene L., et al. Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 2008, 75:272-280.
67. Umar S., de Visser Y.P., Steendijk P., et al. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009, 297:H1606-H1616.
68. van Beem R.T., Noort W.A., Voermans C., et al. The presence of activated CD4(+) T cells is essential for the formation of colony-forming unit-endothelial cells by CD14(+) cells. J Immunol 2008, 180:5141-5148.
69. Voelkel N.F., Tuder R.M. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 1995, 8:2129-2138.
70. Walenta K., Friedrich E.B., Sehnert F., et al. In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology. Biochem Biophys Res Commun 2005, 333:476-482.
71. Wang X.X., Zhang F.R., Shang Y.P., et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007, 49:1566-1571.
72. Weiss D.J. Stem cells and cell therapies for cystic fibrosis and other lung diseases. Pulm Pharmacol Ther 2008, 21:588-594.
73. Wilson D.W., Segall H.J., Pan L.C., et al. Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats. Microvasc Res 1989, 38:57-80.
74. Xia L., Fu G.S., Yang J.X., et al. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension. Cytotherapy 2009, 11:492-502.
75. Xia L., Zhu J.H., Qiu F.Y., et al. Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before-after self-controlled study. J Physiol Sci 2009, 59:429-437.
76. Xue C., Johns R.A. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995, 333:1642-1644.
77. Yao W., Firth A.L., Sacks R.S., et al. Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2009, 296:L870-L878.
78. Yip H.K., Chang L.T., Sun C.K., et al. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Crit Care Med 2008, 36:873-880.
79. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
80. Yoon C.H., Hur J., Park K.W., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618-1627.
81. Yoshida H., Kitaichi T., Urata M., et al. Syngeneic Bone Marrow Mononuclear Cells Improve Pulmonary Arterial Hypertension Through Vascular Endothelial Growth Factor Upregulation. Ann Thorac Surg 2009, 88:418-424.
82. Young K.C., Torres E., Hatzistergos K.E., et al. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res 2009, 104:1293-1301.
83. Zhao Q., Liu Z., Wang Z., et al. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Ann Thorac Surg 2007, 84:544-552.
84. Zhao Y., Courtman D., Deng Y., et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005, 96:442-450.
85. Zhao Y.D., Campbell A.I., Robb M., et al. Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res 2003, 92:984-991.
86. Zhao Y.D., Courtman D.W., Ng D.S., et al. Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer. Am J Respir Cell Mol Biol 2006, 35:182-189.
87. Zhu J.H., Wang X.X., Zhang F.R., et al. Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. Pediatr Transplant 2008, 12:650-655.